• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.25% Nasdaq Up 0.65%

    Transgenomic Inc. (TBIO)

    -NasdaqCM
    0.60 Down 0.01(1.64%) May 27, 4:00PM EDT
    Prev Close:0.61
    Open:0.62
    Bid:0.52 x 1000
    Ask:0.84 x 1000
    1y Target Est:7.00
    Beta:0.216021
    Earnings Date:Aug 11 - Aug 15 (Est.)
    Day's Range:0.58 - 0.64
    52wk Range:0.48 - 3.75
    Volume:87,271
    Avg Vol (3m):142,275
    Market Cap:12.42M
    P/E (ttm):N/A
    EPS (ttm):-2.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TBIO

    Comparison

    Symbol% ChgMkt Cap
    TBIODown 1.64%12.42M
    DGXDown 0.04%10.92B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):11.08
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Transgenomic, Inc., a biotechnology company, engages in advancing personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies, and clinical and research services primarily in... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback